Skip to main content
Erschienen in: BMC Infectious Diseases 1/2010

Open Access 01.12.2010 | Research article

Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis

verfasst von: Christian Østergaard, Stephen L Leib, Ian Rowland, Christian T Brandt

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Bacteremia and systemic complications both play important roles in brain pathophysiological alterations and the outcome of pneumococcal meningitis. Their individual contributions to the development of brain damage, however, still remain to be defined.

Methods

Using an adult rat pneumococcal meningitis model, the impact of bacteremia accompanying meningitis on the development of hippocampal injury was studied. The study comprised of the three groups: I. Meningitis (n = 11), II. meningitis with attenuated bacteremia resulting from iv injection of serotype-specific pneumococcal antibodies (n = 14), and III. uninfected controls (n = 6).

Results

Pneumococcal meningitis resulted in a significantly higher apoptosis score 0.22 (0.18-0.35) compared to uninfected controls (0.02 (0.00-0.02), Mann Whitney test, P = 0.0003). Also, meningitis with an attenuation of bacteremia by antibody treatment resulted in significantly reduced apoptosis (0.08 (0.02-0.20), P = 0.01) as compared to meningitis.

Conclusions

Our results demonstrate that bacteremia accompanying meningitis plays an important role in the development of hippocampal injury in pneumococcal meningitis.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2334-10-1) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CØ designed the study, analyzed the data, and drafted the manuscript. SL participated in the design of the study, performed histopathological analysis, and revised the manuscript. IR helped performing animal experiments and revised the manuscript. CB participated in the design of the study, performed the animal experiments, and revised the manuscript. All authors read and approved the final manuscript.
Abkürzungen
CFU
colony forming units
MRI
magnetic resonance imaging
CSF
cerebrospinal fluid
WBC
white blood cell.

Background

Bacteremia and systemic complications are frequently associated with pneumococcal meningitis and, in approximately half of all fatal cases, are judged to be the primary causes of death [1, 2]. Experimental pneumococcal meningitis studies have shown that accompanying bacteremia not only influenced mortality [3], but also the meningeal inflammatory response [4], cerebral autoregulation [5], and both ventricle size and brain edema [6]. Apoptosis in the dentate gyrus of hippocampus is an important histopathological finding in patients dying from bacterial meningitis [7], and in experimental meningitis, hippocampal apoptosis has been associated with the development of learning deficits (for a review see [8]). Both the invading pathogen [9] and host immune reactions [10, 11] contributed to hippocampal injury during bacterial meningitis. Whilst it has been observed that systemically introduced pneumococci induced apoptosis in a non-meningitis sepsis model [12], the role of accompanying bacteremia on hippocampal apoptosis still remains to be defined in bacterial meningitis. Consequently, we investigated the role of bacteremia in the development of hippocampal apoptosis during experimental pneumococcal meningitis.

Methods

All experimental protocols were approved by the Danish Animal Inspectorate. Meningitis was produced by intracisternal inoculation of ~3 × 104 colony forming units (CFU) Streptococcus pneumoniae, serotype 3 into the cisterna magna of anaesthetized (midazolam (1.88 mg/kg, Dormicum®) and fentanyl/fluanisone (0.12 mg/kg, Hypnorm®)) adult male Wistar rats (300-320 g in weight). The study was performed as part of a previously published magnetic resonance imaging (MRI) study [6].
The study was comprised of 3 experimental groups: I) Meningitis (n = 12). II) Meningitis with an attenuated bacteremia due to treatment with an iv injection of 4.5 g serotype-specific rabbit anti-pneumococcal capsular serotype 3 antiserum (Pneumosera®, Statens Serum Institut, Denmark) at time of bacterial inoculation (n = 14). III) Uninfected control rats (n = 8).
Cerebrospinal fluid (CSF) and blood samples were obtained 28 hours after bacterial inoculation and were analyzed for white blood cell (WBC) count using an automatic cell counter (Medonic CA620 VET, Boule Medical AB, Sweden) and for bacterial concentrations by plating 10-fold serial dilutions. A "disease severity score" included activity (0-4) and characteristics of eyes (0-2) and fur (0-2) as previously described in detail (i.e. 0 = normal; 8 = highest disease severity [13]). Rats were then sacrificed by an overdose of pentobarbital (Mebumal®, Nykomed, Denmark) at 28 hours after inoculation. However, 8 out of 14 rats having an attenuated bacteremia from therapy with serotype-specific antibodies were sacrificed at 38 hours due to a significant better clinical performance at 28 hours compared to the meningitis group (see below). All animals were perfused transcardially with 1.5% paraformaldehyde and their brains removed and stored in 1.5% paraformaldehyde prior to histopathological examination.
For the assessment of hippocampal brain damage, fixed brains were examined for the occurrence of apotosis in the dentate gyrus of the hippocampus. Cryosections (45 μm thick) were stained for Nissl substance with cresyl violet. Quantification of apoptotic nuclei in the hippocampal dentate gyrus was performed as described earlier [10]. In brief, cells exhibiting characteristic histomorphological features of apoptosis were counted in 4 different slices spanning the hippocampus of the right hemisphere. Three visual fields in each of the two blades of the dentate gyrus were inspected for the appearance of cells showing morphological signs indicative of apoptosis (condensed, fragmented dark nuclei, apoptotic bodies; Figure 1E). Each visual field was judged according to the following score: 0-5 cells = 0; 6-20 cells = 1; > 20 cells = 2. A mean value per animal was calculated from all inspected fields (48 fields per animal). Apoptosis was evaluated by a person blinded to the experimental grouping.

Statistically analysis

All results are shown as medians with interquartile range. Comparisons between two groups were performed with Mann Whitney test. Correlation was performed with Spearman rank test. P-values less than 0.05 were considered significant.

Results

As per the study design, blood bacterial concentrations at 28 hours after bacterial inoculation were significantly lower in meningitis rats treated with serotype-specific antibodies (0 Log10 CFU/mL (0-0.9)) as compared to untreated rats with meningitis (2.3 Log10 CFU/mL (1.8-2.9), Mann Whitney test, P = 0.001). Meningitis rats treated with serotype-specific antibodies also had a significantly lower disease severity score than untreated rats with meningitis at 28 hours (3 (2.8-3) vs. 4 (3-5), respectively, P < 0.05), whereas no significant differences in CSF bacterial concentration and in CSF and blood WBC were observed between the two groups. Uninfected controls had no signs of meningitis and a normal disease severity score (for details of laboratory data, see [13]).
As shown in Figure 1, untreated rats with meningitis had a significantly higher score of hippocampal apoptosis (0.22 (0.18-0.35) than uninfected controls (0.02 (0.00-0.02), Mann Whitney P = 0.0003), and when compared to meningitis rats with attenuated bacteremia due to treatment with serotype-specific antibodies (0.08 (0.02-0.20), P = 0.01). No significant difference in apoptosis scores was observed between meningitis rats with attenuated bacteremia that were euthanized at 28 hours or at 38 hours (0.13 (0.04-0.28) vs. 0.05 (0.02-0.15), respectively, P = 0.3), despite rats euthanized at 38 hours having a significantly higher disease severity score (5.0 (4.0-5.8)) than rats euthanized at 28 hours (P < 0.05).
The apoptosis scores correlated significantly with CSF bacterial concentrations, when all meningitis rats were analyzed together (n = 26, rho = 0.52, P = 0.008), but not when analyzed within each experimental group (untreated rats with meningitis: rho = 0.32, P = 0.33, and antibody treated rats: rho = 0.52, P = 0.06). In meningitis rats, no correlation was found between apoptosis scores and disease severity (rho = -0.09, P = 0.67), WBC in CSF (rho = 0.24, P = 0.24), and WBC in blood (rho = 0.10, P = 0.64).

Discussion

In the present study we showed that accompanying bacteremia plays a significant role in development of apoptosis in the dentate gyrus of the hippocampus during pneumococcal meningitis. This is in line with our previous studies and emphasizes the importance of the systemic infection on pathophysiological alterations in meningitis such as the meningeal inflammatory response [4], cerebral autoregulation [5], and brain edema [6] as well as the outcome of pneumococcal meningitis [3]. Whilst several experimental meningitis studies have previously investigated the impact of various adjunctive therapies on the development of apoptosis (for a review see [8]), few reported blood bacterial concentrations [11, 14]. Consequently, for those previous studies where blood bacterial concentrations were not reported, it remains largely unclear whether the anti-inflammatory treatment influenced the degree of bacteremia and subsequent development of hippocampal apoptosis.
Apoptosis in the dentate gyrus of hippocampus is an important histopathological finding in patients dying from bacterial meningitis [7], as well as in experimental meningitis, where hippocampal injury was correlated with the development of learning deficits (for a review see [8]). In contrary, no correlation between hippocampal volume loss (evaluated by MRI volumetric analysis [15]) and academic/behavioral limitation was demonstrated in surviving children with bacterial meningitis. Moreover, disturbance in memory has been correlated to the loss of cerebral volume and to the amount of white matter lesions in surviving adult meningitis patients using MRI [16]. However, this discrepancy could be explained by the relatively low resolution of the MRI studies suggesting that future high field and high resolution MRI studies still are warranted.
The exact mechanism by which bacteremia may influence the development of hippocampal apoptosis remains largely undefined. In accord with this study, Orihuela et al. showed that intravenous injection of pneumococci or pneumococcal cell wall caused neural apoptosis in a non-meningitis sepsis model [12]. Interestingly, the development of hippocampal injury was not secondary to systemic hypotension emerging during the bacteremia [12]. Also, cerebral ischemia from reduced cerebral blood flow/systemic hypotension occurring in experimental meningitis [5] did not significantly influence development of hippocampal injury, since therapy with antioxidants [17] and endothelin-receptor antagonists [18] failed to prevent hippocampal apoptosis, despite preservation of cerebral perfusion and prevention of cortical brain damage. In contrast, the systemic inflammatory response (e.g. sepsis, systemic inflammatory response syndrome) that may accompany bacteremia could play an important role. This is supported by mouse studies where IL-10 deficiency resulted in enhanced neural apoptosis, whilst IL-10 augmentation attenuated neural apoptosis following intravenous administration of pneumococcal cell wall [12]. However, we found no correlation between the hippocampal apoptosis score and the number of blood WBC, hence further studies are still required to investigate the influence of the systemic inflammatory response on hippocampal injury.
A limitation of the present study design was that not all 14 meningitis rats treated with serotype-specific antibodies were euthanized at 28 hours. Eight of these rats were euthanized at 38 hours in the aim to increase the disease severity score of rats with attenuated bacteremia and to mimic meningitis controls regarding disease severity. Since there was no significant difference in apoptosis scores between rats euthanized at 28 or 38 hours, this suggests that the results were not confounded by the time difference. Indeed, Gianinazzi et al. have previously shown, in a time course study over 168 hours, the time-point with maximal degree of hippocampal apoptosis in experimental pneumococcal meningitis (inoculum = ~105 CFU S. pneumoniae, serotype 3) was approximately 38 hours after infection [19].

Conclusions

Our findings continue to underline the significant influence of systemic infection on both outcome and brain pathophysiology in pneumococcal meningitis including the development of hippocampal injury.

Acknowledgements

This work is an "ESCMID Meningitis Study Group" collaborative study. We are most grateful to Angela Bühlmann, University of Bern, for her excellent technical support. The study was supported by the Danish Agency for Science Technology and Innovation (271-05-0416 to CØ) and from the following foundations: Lundbeck Foundation, The A.P. Møller Foundation for Advancement of Medical Science, and The Swiss National Science Foundation (310000-116257 to SLL).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

CØ designed the study, analyzed the data, and drafted the manuscript. SL participated in the design of the study, performed histopathological analysis, and revised the manuscript. IR helped performing animal experiments and revised the manuscript. CB participated in the design of the study, performed the animal experiments, and revised the manuscript. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Østergaard C, Konradsen HB, Samuelsson S: Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according the focus of infection. BMC Infect Dis. 2005, 5: 1-11. 10.1186/1471-2334-5-93.CrossRef Østergaard C, Konradsen HB, Samuelsson S: Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according the focus of infection. BMC Infect Dis. 2005, 5: 1-11. 10.1186/1471-2334-5-93.CrossRef
2.
Zurück zum Zitat Weisfelt M, Beek van de D, Spanjaard L, Reitsma JB, de Gans J: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006, 5: 123-9. 10.1016/S1474-4422(05)70288-X.CrossRefPubMed Weisfelt M, Beek van de D, Spanjaard L, Reitsma JB, de Gans J: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 2006, 5: 123-9. 10.1016/S1474-4422(05)70288-X.CrossRefPubMed
3.
Zurück zum Zitat Brandt CT, Frimodt-Møller N, Lundgren JD, Pedersen M, Skovsted IC, Rowland IJ, Østergaard C: Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis. J Antimicrob Chemother. 2006, 58: 1291-4. 10.1093/jac/dkl401.CrossRefPubMed Brandt CT, Frimodt-Møller N, Lundgren JD, Pedersen M, Skovsted IC, Rowland IJ, Østergaard C: Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis. J Antimicrob Chemother. 2006, 58: 1291-4. 10.1093/jac/dkl401.CrossRefPubMed
4.
Zurück zum Zitat Østergaard C, O'Reilly T, Brandt C, Frimodt-Møller N, Lundgren JD: The influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. BMC Infect Dis. 2006, 6: 1-7. 10.1186/1471-2334-6-1.CrossRef Østergaard C, O'Reilly T, Brandt C, Frimodt-Møller N, Lundgren JD: The influence of the blood bacterial load on the meningeal inflammatory response in Streptococcus pneumoniae meningitis. BMC Infect Dis. 2006, 6: 1-7. 10.1186/1471-2334-6-1.CrossRef
5.
Zurück zum Zitat Pedersen M, Brandt CT, Knudsen GM, Østergaard C, Skinhoj P, Skovsted IC, Frimodt-Moller N, Moller K: The effect of S. pneumoniae bacteremia on cerebral blood flow autoregulation in rats. J Cereb Blood Flow Metab. 2008, 28: 126-34. 10.1038/sj.jcbfm.9600514.CrossRefPubMed Pedersen M, Brandt CT, Knudsen GM, Østergaard C, Skinhoj P, Skovsted IC, Frimodt-Moller N, Moller K: The effect of S. pneumoniae bacteremia on cerebral blood flow autoregulation in rats. J Cereb Blood Flow Metab. 2008, 28: 126-34. 10.1038/sj.jcbfm.9600514.CrossRefPubMed
6.
Zurück zum Zitat Brandt CT, Holm D, Liptrot M, Østergaard C, Lundgren JD, Frimodt-Moller N, Skovsted IC, Rowland IJ: Impact of Bacteremia on the Pathogenesis of Experimental Pneumococcal Meningitis. J Infect Dis. 2008, 197: 235-44. 10.1086/524874.CrossRefPubMed Brandt CT, Holm D, Liptrot M, Østergaard C, Lundgren JD, Frimodt-Moller N, Skovsted IC, Rowland IJ: Impact of Bacteremia on the Pathogenesis of Experimental Pneumococcal Meningitis. J Infect Dis. 2008, 197: 235-44. 10.1086/524874.CrossRefPubMed
7.
Zurück zum Zitat Nau R, Soto A, Bruck W: Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol. 1999, 58: 265-74. 10.1097/00005072-199903000-00006.CrossRefPubMed Nau R, Soto A, Bruck W: Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol. 1999, 58: 265-74. 10.1097/00005072-199903000-00006.CrossRefPubMed
8.
Zurück zum Zitat Grandgirard D, Leib SL: Strategies to prevent neuronal damage in paediatric bacterial meningitis. Curr Opin Pediatr. 2006, 18: 112-8. 10.1097/01.mop.0000193292.09894.b7.CrossRefPubMed Grandgirard D, Leib SL: Strategies to prevent neuronal damage in paediatric bacterial meningitis. Curr Opin Pediatr. 2006, 18: 112-8. 10.1097/01.mop.0000193292.09894.b7.CrossRefPubMed
9.
Zurück zum Zitat Braun JS, Sublett JE, Freyer D, Mitchell TJ, Cleveland JL, Tuomanen EI, Weber JR: Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest. 2002, 109: 19-27.CrossRefPubMedPubMedCentral Braun JS, Sublett JE, Freyer D, Mitchell TJ, Cleveland JL, Tuomanen EI, Weber JR: Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest. 2002, 109: 19-27.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Tauber MG, Leppert D: Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 2001, 124: 1734-42. 10.1093/brain/124.9.1734.CrossRefPubMed Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Tauber MG, Leppert D: Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 2001, 124: 1734-42. 10.1093/brain/124.9.1734.CrossRefPubMed
11.
Zurück zum Zitat Leib SL, Kim YS, Chow LL, Sheldon RA, Tauber MG: Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest. 1996, 98: 2632-9. 10.1172/JCI119084.CrossRefPubMedPubMedCentral Leib SL, Kim YS, Chow LL, Sheldon RA, Tauber MG: Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest. 1996, 98: 2632-9. 10.1172/JCI119084.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Orihuela CJ, Fillon S, Smith-Sielicki SH, El Kasmi KC, Gao G, Soulis K, Patil A, Murray PJ, Tuomanen EI: Cell wall-mediated neuronal damage in early sepsis. Infect Immun. 2006, 74: 3783-9. 10.1128/IAI.00022-06.CrossRefPubMedPubMedCentral Orihuela CJ, Fillon S, Smith-Sielicki SH, El Kasmi KC, Gao G, Soulis K, Patil A, Murray PJ, Tuomanen EI: Cell wall-mediated neuronal damage in early sepsis. Infect Immun. 2006, 74: 3783-9. 10.1128/IAI.00022-06.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Brandt CT, Simonsen H, Liptrot M, Sogaard LV, Lundgren JD, Østergaard C, Frimodt-Moller N, Rowland IJ: In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging. BMC Med Imaging. 2008, 8: 1-10.1186/1471-2342-8-1.CrossRefPubMedPubMedCentral Brandt CT, Simonsen H, Liptrot M, Sogaard LV, Lundgren JD, Østergaard C, Frimodt-Moller N, Rowland IJ: In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging. BMC Med Imaging. 2008, 8: 1-10.1186/1471-2342-8-1.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Wellmer A, von Mering M, Spreer A, Diem R, Eiffert H, Noeske C, Bunkowski S, Gold R, Nau R: Experimental pneumococcal meningitis: Impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice. Infect Immun. 2004, 72: 3113-9. 10.1128/IAI.72.6.3113-3119.2004.CrossRefPubMedPubMedCentral Wellmer A, von Mering M, Spreer A, Diem R, Eiffert H, Noeske C, Bunkowski S, Gold R, Nau R: Experimental pneumococcal meningitis: Impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice. Infect Immun. 2004, 72: 3113-9. 10.1128/IAI.72.6.3113-3119.2004.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat de Jonge RC, Swart JF, Koomen I, Rombouts SA, Gemke RJ, Barkhof F, van Furth AM: No structural cerebral differences between children with a history of bacterial meningitis and healthy siblings. Acta Paediatr. 2008, 97: 1390-6.PubMed de Jonge RC, Swart JF, Koomen I, Rombouts SA, Gemke RJ, Barkhof F, van Furth AM: No structural cerebral differences between children with a history of bacterial meningitis and healthy siblings. Acta Paediatr. 2008, 97: 1390-6.PubMed
16.
Zurück zum Zitat Schmidt H, Heimann B, Djukic M, Mazurek C, Fels C, Wallesch CW, Nau R: Neuropsychological sequelae of bacterial and viral meningitis. Brain. 2006, 129: 333-45. 10.1093/brain/awh711.CrossRefPubMed Schmidt H, Heimann B, Djukic M, Mazurek C, Fels C, Wallesch CW, Nau R: Neuropsychological sequelae of bacterial and viral meningitis. Brain. 2006, 129: 333-45. 10.1093/brain/awh711.CrossRefPubMed
17.
Zurück zum Zitat Loeffler JM, Ringer R, Hablutzel M, Tauber MG, Leib SL: The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis. 2001, 183: 247-52. 10.1086/317921.CrossRefPubMed Loeffler JM, Ringer R, Hablutzel M, Tauber MG, Leib SL: The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis. 2001, 183: 247-52. 10.1086/317921.CrossRefPubMed
18.
Zurück zum Zitat Pfister LA, Tureen JH, Shaw S, Christen S, Ferriero DM, Tauber MG, Leib SL: Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol. 2000, 47: 329-35. 10.1002/1531-8249(200003)47:3<329::AID-ANA8>3.0.CO;2-R.CrossRefPubMed Pfister LA, Tureen JH, Shaw S, Christen S, Ferriero DM, Tauber MG, Leib SL: Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol. 2000, 47: 329-35. 10.1002/1531-8249(200003)47:3<329::AID-ANA8>3.0.CO;2-R.CrossRefPubMed
19.
Zurück zum Zitat Gianinazzi C, Grandgirard D, Imboden H, Egger L, Meli DN, Bifrare YD, Joss PC, Tauber MG, Borner C, Leib SL: Caspase-3 mediates hippocampal apoptosis in pneumococcal meningitis. Acta Neuropathol (Berl). 2003, 105: 499-507. Gianinazzi C, Grandgirard D, Imboden H, Egger L, Meli DN, Bifrare YD, Joss PC, Tauber MG, Borner C, Leib SL: Caspase-3 mediates hippocampal apoptosis in pneumococcal meningitis. Acta Neuropathol (Berl). 2003, 105: 499-507.
Metadaten
Titel
Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis
verfasst von
Christian Østergaard
Stephen L Leib
Ian Rowland
Christian T Brandt
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2010
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-1

Weitere Artikel der Ausgabe 1/2010

BMC Infectious Diseases 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.